Advances in the diagnosis, evaluation and management of cholangiocarcinoma
Authors:
- Tushar PatelTPTushar Patel
- 1 May 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 22 (3) , 294-299
Abstract
Cholangiocarcinoma is an enigmatic malignancy of the biliary tract that has recently been shown to be increasing in incidence globally. There has been recent progress in identifying potential risk factors for the tumor, and in the use of emerging technologies for diagnosis and palliative treatment. Hepatitis B and C, cirrhosis and alcohol have been described as risk factors for cholangiocarcinoma. A morphology-based classification for cholangiocarcinoma is proposed that will facilitate future descriptive epidemiology, diagnosis and comparative therapeutic studies. Diagnosis may be improved by new approaches to enhance the diagnostic yield and utility of biliary cytology. The role of new imaging approaches such as positron emission tomography scanning, endoscopic ultrasound or optical coherence tomography for diagnosis are being examined and defined. Long-term results for transplantation protocols for curative intent in non-resectable localized disease have been described. Photodynamic therapy looks extremely promising for adjunct therapy of intrahepatic mass lesions. Recent advances in the epidemiology, classification, diagnosis and therapy of cholangiocarcinoma are expected to enhance the evaluation and management of patients with this devastating malignancy.Keywords
This publication has 36 references indexed in Scilit:
- CholangiocarcinomaThe Lancet, 2005
- The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing CholangitisDigestive Diseases and Sciences, 2005
- Characterization of Intrahepatic Cholangiocarcinoma of the Intraductal Growth-Type and Its Precursor Lesions *Hepatology, 2005
- Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation StudyJournal of Clinical Oncology, 2005
- The value of biliary amylase and Hepatocarcinoma–Intestine–Pancreas/Pancreatitis-associated Protein I (HIP/PAP-I) in diagnosing biliary malignanciesClinical Biochemistry, 2005
- Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinomaEuropean Journal Of Cancer Prevention, 2005
- CholangiocarcinomaGastroenterology, 2005
- Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control studyGastroenterology, 2005
- Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinomaHepatology, 2000
- The Effect of Benign and Malignant Liver Disease on the Tumour Markers CA19-9 and CEAAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1998